Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Astellas : FDA Grants Priority Review For SBLA Of Padcev Combination For Bladder Cancer Treatment
posted:
Thu, 11/30/2023 - 20:52 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Biotech Stocks Facing FDA Decision In December 2023
posted:
Thu, 11/30/2023 - 02:53 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
US FDA investigating safety risk of CAR-T cancer therapies
posted:
Tue, 11/28/2023 - 18:19 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
US FDA cautions on use of Philips' sleep apnea machines
posted:
Tue, 11/28/2023 - 17:28 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Carisma Therapeutics Gets FDA Clearance To Start Phase 1 Study Of CT-0525 In Solid Tumors
posted:
Tue, 11/28/2023 - 07:22 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Carisma Therapeutics Announces FDA Clearance Of IND For CT-0525 - Quick Facts
posted:
Tue, 11/28/2023 - 07:15 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Abeona Therapeutics: FDA Grants Priority Review For Pz-cel BLA
posted:
Mon, 11/27/2023 - 07:49 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
FDA Approves Medtronic's Symplicity Spyral Renal Denervation System For Hypertension Treatment
posted:
Sat, 11/18/2023 - 00:05 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Dermata (DRMA) Up on FDA Nod to Begin Pivotal Study of Acne Drug
posted:
Fri, 11/17/2023 - 09:06 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Pfizer, Astellas' XTANDI Gets FDA Approval For Nonmetastatic Castration-sensitive Prostate Cancer
posted:
Thu, 11/16/2023 - 23:14 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
US FDA staff flags concerns on Merck's chronic cough drug
posted:
Wed, 11/15/2023 - 12:39 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
BioCardia: FDA Approves CardiAMP Heart Failure II Protocol For Autologous Cell Therapy
posted:
Tue, 11/14/2023 - 08:05 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Lipella Pharma: FDA Grants Orphan Designation For LP-310 To Treat Oral Graft-versus-Host Disease
posted:
Fri, 11/10/2023 - 08:17 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
FDA Approves World's First Chikungunya Vaccine Developed By Valneva
posted:
Fri, 11/10/2023 - 01:57 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
FDA approves Valneva's Chikungunya vaccine for adults
posted:
Fri, 11/10/2023 - 01:14 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Pagination
Previous page
‹‹
Page 9
Next page
››